Mitoxantrone: Clinical Trials

10 trials of Mitoxantrone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 3 unknown, 1 not yet recruiting. 10 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 410Completed 6, Unknown 3, Not yet recruiting 1

Follow Mitoxantrone: new trials by email Literature Review of Mitoxantrone trials Research Report on Mitoxantrone

Trials (filtered) newest first · largest first

All 10 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Application of Mitoxantrone Hydrochloride Injection in Transoral Robotic Thyroid Cancer Surgery
mitoxantrone hydrochloride injection - Papillary Thyroid Cancer
Phase 4Not yet recruitingDaping Hospital and the Research Institute of Surgery of the Third Military Medical University1142026-02-012026-01-21
A Study for Improving the Outcome of Childhood Acute Promyeloid Leukemia
ATO, RIF, ATRA - Childhood Acute Promyelocytic Leukemia
Phase 4CompletedSouth China Children's Leukemia Group1762011-09-012022-05-10
3 Anthracyclines, 2 Types of Consolidation With Different ARA-C Doses and Maintenance in Adult Acute Myeloid Leukemia
high dose ARA-C, standard dose ARA-C - Acute Myeloid Leukemia
Phase 4UnknownNational Research Center for Hematology, Russia2452010-01-012014-04-07
Efficacy and Safety of Mitoxantrone in Patients With Refractory Neuromyelitis Optica and Spectrum Disorders
Mitoxantrone - Neuromyelitis Optica, Neuromyelitis Optica Spectrum Disorders
Phase 4UnknownXuanwu Hospital, Beijing502009-03-012013-12-27
Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)
ATRA, Idarubicina, Mitoxantrone - Acute Promyelocytic Leukemia
Phase 4CompletedPETHEMA Foundation3002005-07-012014-10-28
Treatment of High Risk Adult Acute Lymphoblastic Leukemia
Vincristine, Daunorubicin, Prednisone - Acute Lymphoblastic Leukemia
Phase 4CompletedPETHEMA Foundation1002003-01-012020-04-07
A Pilot Study of Mitoxantrone for the Treatment of Recurrent Neuromyelitis Optica (Devic's Disease)
Mitoxantrone - Neuromyelitis Optica, Myelitis, Transverse
Phase 4CompletedState University of New York at Buffalo52001-08-012020-12-28
AIDA2000 - Risk-Adapted Therapy for Patients With Acute Promyelocytic Leukemia
all-trans retinoid acid, idarubicin, mitoxantrone - Leukemia, Promyelocytic, Acute
Phase 4UnknownTechnische Universität Dresden802000-01-012011-07-11
LAL-Ph-2000: Treatment of Acute Lymphoblastic Leukemia Chromosome Philadelphia Positive
Vincristine, Daunorubicin, Prednisone - Acute Lymphoblastic Leukemia
Phase 4CompletedPETHEMA Foundation1002000-01-012010-01-05
German Multicenter Trial for Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Adults (05/93)
Asparaginase, Vincristine, Daunorubicin, Adriamycin - Adult Acute Lymphocytic Leukemia
Phase 4CompletedGoethe University7201993-04-012023-03-17

Conditions studied

Precursor Cell Lymphoblastic Leukemia-Lymphoma (3)  ·  Leukemia, Promyelocytic, Acute (2)  ·  Neuromyelitis Optica (2)  ·  Autoimmune Diseases of the Nervous System (1)  ·  Demyelinating Autoimmune Diseases, CNS (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelitis, Transverse (1)  ·  Recurrence (1)  ·  Thyroid Cancer, Papillary (1)

Sponsors

PETHEMA Foundation (3)  ·  Daping Hospital and the Research Institute of Surgery of the Third Military Medical University (1)  ·  Goethe University (1)  ·  National Research Center for Hematology, Russia (1)  ·  South China Children's Leukemia Group (1)  ·  State University of New York at Buffalo (1)  ·  Technische Universität Dresden (1)  ·  Xuanwu Hospital, Beijing (1)

Countries

China (3)  ·  Spain (3)  ·  Germany (2)  ·  Poland (1)  ·  Russia (1)  ·  United States (1)  ·  Uruguay (1)

Top investigators

Bianca Weinstock-Guttman, M.D. (1)  ·  Dieter Hoelzer, MD, PhD (1)  ·  Gerhard Ehninger, MD (1)  ·  Huiqing Dong, Doctor (1)  ·  Lowenberg Bob, Dr (1)  ·  San Miguel Miguel Angel, Dr (1)  ·  Valeriy G Savchenko (1)  ·  Vellenga Edo, Dr (1)  ·  Xue-Qun Luo, professor (1)

Results publications

PMID 16831964, PMID 20393132, PMID 21148082, PMID 24752047, PMID 25314773, PMID 25975975, PMID 28584252, PMID 35760920, PMID 39781038